Ranexa 1gm (Ranolazine Extended Release Tablet) 1gm

Ranexa 1gm (ranolazine extended release) is a prescription medication used for chronic angina management. This 1gm tablet formulation provides extended-release support for consistent symptom control. Store at ambient temperature and follow healthcare provider guidance for safe use.

Strength

1gm

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

GILEAD USA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ranexa 1gm is used to treat chronic angina, a condition marked by chest pain due to reduced blood flow to the heart. It helps improve exercise tolerance and reduce angina episodes when other treatments aren’t sufficient. This extended-release tablet works gradually to support steady symptom management throughout the day.

Side Effects

Ranexa 1gm may help reduce the frequency of chest pain episodes and improve physical activity tolerance for those with chronic angina. Users often report more consistent energy levels and fewer disruptions from angina symptoms during daily routines. Individual responses may vary based on medical history and treatment plan.

Precautions & Warnings

Keep Ranexa 1gm in a cool, dry place away from direct sunlight and out of reach of children. Do not crush, chew, or split the tablet, as this can affect how the medication releases. Inform your healthcare provider about all medications and conditions before starting ranolazine.

Avoid Interactions

Ranolazine may interact with other medications that affect heart rhythm or are metabolized by the liver, such as certain antibiotics or antifungals. Grapefruit products can increase ranolazine levels in the body, so avoid consuming grapefruit while taking this medication. Always review your full medication list with a healthcare professional.

References

Frequently Asked Questions

Ranolazine is used to treat chronic angina in adults, helping reduce chest pain and improve exercise tolerance.

Store Ranexa 1gm at ambient room temperature, away from moisture and heat, and keep the container tightly closed.

No, do not split, crush, or chew Ranexa 1gm tablets, as this affects the extended-release mechanism.

Yes, grapefruit and grapefruit juice may increase ranolazine levels in your blood, so avoid consuming them.

Ranexa 1gm is not primarily a blood pressure medication, though it may have effects on heart-related symptoms.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.